SIRT2 and Parkinson disease: Second, an increase in SIRT2 levels has been described in different neuropsychiatric and neurodegenerative diseases including AD [29,39], PD [50,59,60,61], and Huntington’s disease (HD) [62], both in mouse models and human postmortem brain tissues (Table 2).